Cargando…
Global implementation of PrEP for HIV prevention: setting expectations for impact
INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712462/ https://www.ncbi.nlm.nih.gov/pubmed/31456348 http://dx.doi.org/10.1002/jia2.25370 |
_version_ | 1783446685678043136 |
---|---|
author | Pyra, Maria N Haberer, Jessica E Hasen, Nina Reed, Jason Mugo, Nelly R Baeten, Jared M |
author_facet | Pyra, Maria N Haberer, Jessica E Hasen, Nina Reed, Jason Mugo, Nelly R Baeten, Jared M |
author_sort | Pyra, Maria N |
collection | PubMed |
description | INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence, and persistence and their combined impact on the epidemic. DISCUSSION: Targets for PrEP uptake must be based on the local HIV epidemic and will depend on appropriate estimates of the key populations at risk for HIV. However, there is evidence that targets, once established, can successfully be met and that uptake may increase with awareness. Messaging around adherence should include that daily adherence is the goal (except for those MSM for whom event‐driven dosing is a good fit), but perfect adherence should not be a barrier. Ideally, clients persist on PrEP for as long as they are at risk for HIV. While PrEP will be most effective when coverage is focused on high‐risk populations, normalizing rather than stigmatizing PrEP will be highly beneficial. CONCLUSIONS: While many challenges to PrEP implementation exist, we focused on the three key steps of uptake, adherence and persistence as measurable processes that can lead to improved coverage and decreased HIV incidence. |
format | Online Article Text |
id | pubmed-6712462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67124622019-09-04 Global implementation of PrEP for HIV prevention: setting expectations for impact Pyra, Maria N Haberer, Jessica E Hasen, Nina Reed, Jason Mugo, Nelly R Baeten, Jared M J Int AIDS Soc Commentary INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence, and persistence and their combined impact on the epidemic. DISCUSSION: Targets for PrEP uptake must be based on the local HIV epidemic and will depend on appropriate estimates of the key populations at risk for HIV. However, there is evidence that targets, once established, can successfully be met and that uptake may increase with awareness. Messaging around adherence should include that daily adherence is the goal (except for those MSM for whom event‐driven dosing is a good fit), but perfect adherence should not be a barrier. Ideally, clients persist on PrEP for as long as they are at risk for HIV. While PrEP will be most effective when coverage is focused on high‐risk populations, normalizing rather than stigmatizing PrEP will be highly beneficial. CONCLUSIONS: While many challenges to PrEP implementation exist, we focused on the three key steps of uptake, adherence and persistence as measurable processes that can lead to improved coverage and decreased HIV incidence. John Wiley and Sons Inc. 2019-08-28 /pmc/articles/PMC6712462/ /pubmed/31456348 http://dx.doi.org/10.1002/jia2.25370 Text en © 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Pyra, Maria N Haberer, Jessica E Hasen, Nina Reed, Jason Mugo, Nelly R Baeten, Jared M Global implementation of PrEP for HIV prevention: setting expectations for impact |
title | Global implementation of PrEP for HIV prevention: setting expectations for impact |
title_full | Global implementation of PrEP for HIV prevention: setting expectations for impact |
title_fullStr | Global implementation of PrEP for HIV prevention: setting expectations for impact |
title_full_unstemmed | Global implementation of PrEP for HIV prevention: setting expectations for impact |
title_short | Global implementation of PrEP for HIV prevention: setting expectations for impact |
title_sort | global implementation of prep for hiv prevention: setting expectations for impact |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712462/ https://www.ncbi.nlm.nih.gov/pubmed/31456348 http://dx.doi.org/10.1002/jia2.25370 |
work_keys_str_mv | AT pyramarian globalimplementationofprepforhivpreventionsettingexpectationsforimpact AT habererjessicae globalimplementationofprepforhivpreventionsettingexpectationsforimpact AT hasennina globalimplementationofprepforhivpreventionsettingexpectationsforimpact AT reedjason globalimplementationofprepforhivpreventionsettingexpectationsforimpact AT mugonellyr globalimplementationofprepforhivpreventionsettingexpectationsforimpact AT baetenjaredm globalimplementationofprepforhivpreventionsettingexpectationsforimpact |